UBS O'Connor’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

UBS O'Connor’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-656,992	Closed	-$6.56M	–	881
2022 Q3	$6.56M	Sell	656,992 -65,891	-9%	-$655K	0.07%	170
2022 Q2	$7.14M	Buy	+722,883	New	+$7.13M	0.07%	168
2022 Q1	–	Sell	-512,191	Closed	-$5M	–	756
2021 Q4	$5M	Buy	512,191 +13,730	+3%	+$135K	0.05%	274
2021 Q3	$4.88M	Buy	498,461 +200,783	+67%	+$1.97M	0.04%	297
2021 Q2	$2.98M	Sell	297,678 -102,307	-26%	-$1.04M	0.03%	388
2021 Q1	$4.09M	Buy	+399,985	New	+$4.74M	0.06%	302

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS O'Connor's HAAC Position: Q4 2022 in Review

UBS O'Connor sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 656,992 shares — an estimated $6.56M sold.

UBS O'Connor first reported a position in HAAC in Q1 2021 and held it in 6 quarters. The position peaked at $7.14M in Q2 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

UBS O'Connor reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 656,992 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6.56M.
UBS O'Connor first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
UBS O'Connor's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $7.14M in Q2 2022.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.